Paradigm Peptides permanently shut down in March 2024
Owner Matthew Kawa and his sister Jennifer Stechkober pleaded guilty to selling unapproved drugs and were sentenced in July 2026 to 70 and 16 months in prison. According to the U.S. Attorney's Office for the Northern District of Indiana, the company imported its products from China and India, did not test them, and falsely claimed US manufacturing, FDA registration and third-party testing; SARMs it sold were found to contain testosterone. Websites using the Paradigm Peptides name today are not the original company.
Paradigm Peptides
Former US research peptide and SARM seller that shut down in March 2024. Its owner was sentenced in 2026 for selling unapproved, untested drugs.
Disclaimer: This page is for informational purposes only. Vendor listings may contain affiliate links. Research peptides are intended for laboratory and research use only. See our affiliate disclosure for details.
